The authors concluded, GLP- 1RA therapy was associated with a significantly lower epilepsy risk compared with DPP-4i use in adults with T2DM [type 2 diabetes]
This precision approach ensures your body receives exactly what it needs to thrive on semaglutide therapy
Clear protocols Read More GLP-1 Drug Interactions: Why New Prescribing Patterns Are Raising Concerns Mar 26, 2026 Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity 6,376 views Concerns about GLP-1 drug interactions are rising as these therapies gain widespread use in diabetes and obesity management
Additionally, the results revealed elevated levels of IGF-1 and IGFBP3, increased skin thickness, and an increase in lean body mass
Additionally, patients should be informed that insurance coverage for compounded medications is often limited or unavailable, and that once brand-name products are no longer in shortage, continued use of compounded versions may not be appropriate or legal under FDA regulations